AI eye on the heart: new tool could catch silent attacks

NCT ID NCT07077057

Recruiting now Diagnosis Sponsor: Cardiocentro Ticino Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an artificial intelligence (AI) tool can help doctors identify heart attacks that standard ECG tests miss. About 500 adults with chest pain but no clear signs of a heart attack on their initial ECG will be randomly assigned to get either AI-assisted or standard ECG reading. The goal is to see if the AI speeds up treatment and reduces heart damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted ECG interpretation (PMcardio)
What this could lead to: If it works, this could help doctors detect heart attacks earlier in people whose initial ECG looks normal, potentially saving heart muscle and lives.
What could go wrong: This is a single-center trial with 500 people, so results may not apply everywhere. The AI tool is an aid, not a replacement for a doctor's judgment, and could still miss some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME (ACS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME (ACS) MYOCARDIAL INFARCTION (MI)

Contacts and locations

Locations

Cardiocentro Ticino Institute
RECRUITING

Lugano, Canton Ticino, 6900, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.